Zygter 250 Tablet | Terbinafine Hydrochloride 250 mg | Oral Antifungal Medicine | 7 Tablets

Product Introduction: Zygter 250 Tablet is an oral antifungal medicine containing Terbinafine Hydrochloride IP equivalent to Terbinafine 250 mg. It is manufactured by Pure & Cure Healthcare Pvt. Ltd. and marketed by Encore Healthcare Private Limited. Terbinafine belongs to the allylamine class of antifungal medicines. It works by interfering with the formation of ergosterol, an essential component of fungal cell membranes. This action helps eliminate susceptible fungi responsible for certain skin and nail infections. Zygter 250 should be taken only on the prescription of a registered medical practitioner. The dose and duration depend on the type, location and severity of the fungal infection. Uses: Zygter 250 Tablet may be prescribed for susceptible fungal infections, including: Fungal infections of the toenails (onychomycosis). Fungal infections of the fingernails. Ringworm infections of the body (tinea corporis). Fungal infections of the groin (tinea cruris). Fungal infections of the feet (tinea pedis). Other susceptible dermatophyte infections, as diagnosed by a doctor. Note: Oral terbinafine is not suitable for every type of fungal infection. Its use depends on the organism responsible for the infection. Key Ingredients & Full Ingredients: Active Ingredient: Terbinafine Hydrochloride IP. Equivalent Strength: Terbinafine 250 mg per tablet. Formulation: Uncoated tablet. Additional formulation information: With Betacyclodextrin. Complete composition as printed on the packaging: Each uncoated tablet contains: Terbinafine Hydrochloride IP equivalent to Terbinafine 250 mg (With Betacyclodextrin). Individual inactive excipients are not separately listed on the supplied packaging. Benefits: Helps treat susceptible dermatophyte fungal infections. Provides systemic antifungal action through oral administration. May be prescribed for fungal infections affecting the skin and nails. Works by disrupting an essential component of fungal cell membranes. 250 mg strength provides a convenient once-daily formulation when prescribed. Can help clear fungal nail infections over the prescribed treatment course. Side Effects: Some people may experience side effects while taking oral terbinafine. Common or relatively frequent side effects: Headache. Nausea. Diarrhoea. Stomach discomfort or indigestion. Abdominal pain. Skin rash or itching. Changes in taste. Reduced appetite. Serious but less common side effects: Liver injury, including hepatitis. Severe allergic reactions. Blistering or peeling skin reactions. Significant changes in blood cell counts. Persistent or severe loss of taste or smell. Seek immediate medical attention if you develop yellowing of the skin or eyes, dark urine, pale stools, persistent nausea, unusual fatigue, severe abdominal pain, facial swelling or difficulty breathing. Stop taking the medicine and contact your doctor urgently if symptoms suggest liver injury or a serious skin reaction. Product Form: Dosage Form: Uncoated Tablet Route of Administration: Oral Strength: 250 mg Pack Size: 1 × 7 Tablets Brand Name: Zygter Active Ingredient: Terbinafine Therapeutic Category: Antifungal Medicine How to Use: Take Zygter 250 Tablet strictly as prescribed by your doctor. Swallow the tablet with a glass of water. Take it at the recommended time each day. It may generally be taken with or without food, unless your doctor advises otherwise. Complete the prescribed treatment course, even if the visible symptoms improve. Do not increase, decrease or discontinue the dose without medical advice. Important: The packaging states "Dosage: As directed by the Physician." The number of tablets in the pack does not indicate the prescribed treatment duration. How it Works: Terbinafine is an allylamine antifungal medicine that acts against susceptible fungi. It inhibits an enzyme called squalene epoxidase in fungal cells. This blocks the production of ergosterol, an essential component of fungal cell membranes. It also causes the accumulation of squalene inside fungal cells. These changes disrupt fungal cell membrane function and can lead to fungal cell death. Terbinafine is particularly effective against dermatophytes, the fungi responsible for many skin and nail infections. 3. Medical & Safety Information Safety Advice: Liver conditions: Oral terbinafine should not be used in patients with chronic or active liver disease. Liver function assessment is recommended before treatment and monitoring may be required during therapy. Kidney conditions: Inform your doctor if you have impaired kidney function. Dose suitability requires medical assessment. Pregnancy: Oral terbinafine is generally not recommended during pregnancy unless the doctor determines that treatment is necessary. Breastfeeding: Consult your doctor before use because terbinafine passes into breast milk. Alcohol: Avoid excessive alcohol consumption. Discuss alcohol use with your doctor, particularly because terbinafine can affect the liver. Driving: Terbinafine may cause dizziness or changes in taste or smell. Avoid driving or operating machinery if you feel unwell or dizzy. Allergies: Do not take this medicine if you have a known allergy to terbinafine or any of its ingredients. Medical monitoring: Your doctor may recommend liver function tests before and during treatment. FDA Access Data+3 Quick Tips: Maintain good personal hygiene during treatment. Keep the affected skin clean and dry. Change socks regularly if you have athlete's foot. Avoid sharing towels, footwear or nail-care equipment. Keep nails trimmed and clean if treating a nail infection. Wear breathable footwear to reduce moisture accumulation. Complete the prescribed course to reduce the risk of recurrence. Do not use another person's antifungal medicine. Seek medical advice if the infection persists or worsens. Fact Box: Product Attribute Details Brand Zygter Generic Name Terbinafine Strength 250 mg Dosage Form Uncoated Tablet Route Oral Pack Size 1 × 7 Tablets Therapeutic Class Antifungal Drug Class Allylamine Therapeutic Use Susceptible fungal infections Prescription Required Yes Habit Forming No Controlled Medicine No Antibiotic No Steroid No Sugar Content Not specified Suitable Age Group As prescribed by a doctor Storage Temperature Not exceeding 30°C Dietary Restrictions No specific food restriction generally; follow medical advice Manufacturer Country India Interaction with Drugs: Terbinafine can interact with certain medicines and affect their metabolism. Inform your doctor about all prescription medicines, OTC products, vitamins and herbal supplements you use. Important interactions include: Medicine / Drug Class Potential Interaction Antidepressants (including TCAs and some SSRIs) May increase or alter drug concentrations Beta-blockers May increase their effects or exposure Antiarrhythmics May affect the metabolism of certain heart medicines Warfarin May alter anticoagulant response Cimetidine May increase terbinafine exposure Rifampicin May reduce terbinafine exposure Fluconazole May increase terbinafine exposure Cyclosporine May alter cyclosporine exposure Tamoxifen May potentially reduce its activation through CYP2D6 inhibition Codeine and Tramadol May alter their effects or increase adverse effects Caffeine May increase caffeine exposure or effects Important: This is not a complete interaction list. A doctor or pharmacist should review your medication history before treatment. NHS+3 4. Business Details Manufacturer, Importer, and Marketer: Manufactured in India by: Pure & Cure Healthcare Pvt. Ltd. (A subsidiary of Akums Drugs & Pharmaceuticals Ltd.) Plot No. 26A, 27-30, Sector-8A, I.I.E., SIDCUL, Ranipur, Haridwar (Uttarakhand) - 249 403. Manufacturing Licence Number: 31/UA/2013 Marketed in India by: ENCORE Healthcare Private Limited 4th floor, Meher Chambers, R. K. Marg, Ballard Estate, Fort, Mumbai - 400001. Importer: Not mentioned on the supplied packaging. Packaging Details: Brand: Zygter Composition: Terbinafine Hydrochloride IP equivalent to Terbinafine 250 mg Pack: 1 × 7 Tablets Storage: Store at a temperature not exceeding 30°C, protected from light and moisture. Warning: Keep out of reach of children. Prescription Warning: Not to be sold by retail without the prescription of a Registered Medical Practitioner. 5. FAQs Q1. What is Zygter 250 Tablet used for? Zygter 250 contains Terbinafine 250 mg, an antifungal medicine prescribed for susceptible fungal infections, particularly dermatophyte infections affecting the skin and nails. Q2. Does Zygter 250 Tablet help treat nail fungus? Yes. Oral terbinafine is commonly prescribed for dermatophyte-related fingernail and toenail infections. Visible improvement may take several months because healthy nails need time to grow. Q3. How long does Zygter 250 take to work? The response depends on the type and severity of the infection. Skin infections may improve earlier, while nail infections can take several months to show visible improvement. Follow the duration prescribed by your doctor. Q4. Can Zygter 250 Tablet cause liver problems? Yes. Oral terbinafine can rarely cause serious liver injury. Patients should undergo appropriate medical assessment and report symptoms such as yellow eyes, dark urine, persistent nausea or unusual tiredness immediately. Q5. Is Zygter 250 Tablet available without a prescription? No. The supplied packaging specifically states that it must not be sold by retail without a prescription from a Registered Medical Practitioner.